A new study reveals that dual-atom catalysts behave in a fundamentally different way than scientists previously thought, challenging a long-standing model used to predict catalytic performance.
Researchers have developed a way to program human cells to perform calculations and make autonomous decisions, similar to how ...
Decades ago, Paul Erdős used randomness to illuminate the vast and weird world of networks. Now mathematicians are making his ...
How the proteins in our bodies bind together to form protein complexes plays a critical role in numerous cell functions—staving off diseases, for instance, or transporting ions across cell membranes.
Abstract: Despite the remarkable progress in synthetic aperture radar automatic target recognition (SAR ATR), recent efforts have concentrated on detecting and classifying a specific category, e.g., ...
Version 0.3.17 or latest supports qwen3-VL. Version 0.3.30 or latest supports qwen3.5. Version 0.3.35 or latest supports gemma4.
(MENAFN- Khaleej Times) For decades, governments measured progress by how efficiently they delivered services. Today, a more demanding benchmark is taking shape: how effectively public institutions ...
This repository is a collection of reference implementations for the Model Context Protocol (MCP), as well as references to community-built servers and additional resources. Important If you are ...
I’ve been writing and editing technology articles for more than seven years, most recently as part of PCMag's software team. I am responsible for content in the AI, financial, graphic design, ...
Abstract: Buildings are major contributors to global electricity consumption and emission, making the development of effective Building Energy Management Systems (BEMS) essential for improving energy ...
shows the logo of Microsoft displayed on the facade of the company France headquarters in Issy-les-Moulineaux, on the outskirts of Paris, on April 24, 2026. Martin LELIEVRE/Getty Images Microsoft ...
An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results